We Need Granular Sharing of De-Identified Data—But Will Patients Engage? Investigating Health System Leaders' and Patients' Perspectives on a Patient-Controlled Data-Sharing Platform
We Need Granular Sharing of De-Identified Data-But Will Patients Engage? Investigating Health System Leaders' and Patients' Perspectives on A Patient-Controlled Data-Sharing Platform
HCI Today summarized the key points
- •This article examines the value and limitations of a consent platform that lets patients directly control the sharing of medical data, drawing on perspectives from two groups.
- •The research team developed a high-fidelity prototype of a patient-led, web-based consent platform and surveyed 16 healthcare system leaders and 523 patients.
- •Both groups acknowledged the benefits of transparency and autonomy, but there were clear differences in how they interpreted granular control and the sharing of anonymized data.
- •Leaders viewed this as consent grounded in adequate explanation and as an institutional ethics issue, while patients understood it as a safety mechanism that reduces risk and uncertainty.
- •The study highlights the tension between personal control and the credibility of research, and suggests that design is needed to accommodate varying levels of understanding and privacy requirements.
This summary was generated by an AI editor based on HCI expert perspectives.
Why Read This from an HCI Perspective
This article clearly shows that patient-controlled data sharing is not just a matter of adding features—it requires redesigning trust, explainability, and the consent experience itself. In particular, the fact that patients and institutional leaders interpret the same ‘transparency’ and ‘granular control’ through different risk-management mechanisms is especially important for HCI/UX practitioners. It’s a useful case for thinking about how to reconcile differences in user perceptions in sensitive contexts like medical data.
CIT's Commentary
The core of this study is less about the technical granularity (granular control) itself and more about how different stakeholders interpret what that granularity means. Patients tend to see it as a safety mechanism that reduces risk and uncertainty, while institutional leaders interpret it through the lens of ethical consent and research legitimacy. This difference demonstrates that simply offering ‘more choice’ does not always lead to a better experience. Therefore, design should not stop at increasing the level of control; it must also address contextual explanations for why data are shared, provide information tailored to users’ levels of understanding, and maintain transparency that is updated over time. The study reinforces that trust in healthcare data platforms is not a feature—it is a design of relationships.
Questions to Consider While Reading
- Q.To ensure that granular consent options don’t actually increase choice fatigue, what kinds of default levels and guidance structures are needed?
- Q.Some elements that look like safety mechanisms to patients may feel like constraints on data use to researchers—how can this tension be adjusted through interaction design?
- Q.How can ‘ongoing, benefit-centered transparency’ be personalized for users with varying health literacy and privacy sensitivity?
This commentary was generated by an AI editor based on HCI expert perspectives.
Please refer to the original for accurate details.
Subscribe to Newsletter
Get the weekly HCI highlights delivered to your inbox every Friday.